Healthpeak Properties (NYSE:DOC) Hits New 1-Year High After Analyst Upgrade

Posted by Brian Himes on May 14th, 2026

Healthpeak Properties, Inc. (NYSE:DOC – Get Free Report) reached a new 52-week high during trading on Thursday after UBS Group raised their price target on the stock from $17.00 to $19.00. UBS Group currently has a neutral rating on the stock. Healthpeak Properties traded as high as $19.91 and last traded at $19.7760, with a volume of 1517813 shares changing hands. The stock had previously closed at $19.55.

DOC has been the topic of a number of other research reports. Weiss Ratings raised shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Wall Street Zen raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday. Morgan Stanley decreased their target price on shares of Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 28th. Citigroup upped their target price on shares of Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research report on Tuesday. Finally, Argus cut shares of Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Four research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $18.75.

Read Our Latest Stock Analysis on Healthpeak Properties

Insiders Place Their Bets

In related news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.23% of the stock is currently owned by company insiders.

Institutional Trading of Healthpeak Properties

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Advocate Investing Services LLC acquired a new stake in Healthpeak Properties during the fourth quarter worth approximately $26,000. WPG Advisers LLC raised its holdings in Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after purchasing an additional 1,197 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new position in shares of Healthpeak Properties during the second quarter worth approximately $33,000. Clearstead Advisors LLC grew its position in shares of Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after acquiring an additional 1,216 shares during the last quarter. Finally, Elyxium Wealth LLC purchased a new position in shares of Healthpeak Properties during the fourth quarter worth approximately $31,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 1.4%

The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. The firm has a market capitalization of $13.66 billion, a PE ratio of 61.82, a price-to-earnings-growth ratio of 2.73 and a beta of 1.00. The business’s 50-day moving average price is $17.19 and its 200-day moving average price is $17.19.

Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The business had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period last year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, analysts expect that Healthpeak Properties, Inc. will post 1.74 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be given a dividend of $0.1017 per share. The ex-dividend date is Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 6.2%. Healthpeak Properties’s dividend payout ratio (DPR) is 381.25%.

About Healthpeak Properties

(Get Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.